2021
Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study.
Hruska CB, Geske JR, Conners AL, Whaley DH, Rhodes DJ, O'Connor MK, Carter RE, Scott CG, Vachon CM. Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study. American Journal Of Roentgenology 2021, 216: 1193-1204. PMID: 32755210, PMCID: PMC8640999, DOI: 10.2214/ajr.20.23854.Peer-Reviewed Original ResearchConceptsBackground parenchymal uptakeMolecular breast imagingPostmenopausal womenBreast cancer riskAbsolute riskBreast cancerCohort studyDiscriminatory accuracyDense breastsRisk factorsParenchymal uptakeCancer riskRisk scoreFuture breast cancer diagnosisGreater breast cancer riskBreast cancer risk factorsCox proportional hazards modelGail risk scoreBreast cancer eventsIndependent risk factorSubset of womenCancer risk factorsCase-control studyProportional hazards modelBreast cancer diagnosis
2016
Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
Hruska CB, Scott CG, Conners AL, Whaley DH, Rhodes DJ, Carter RE, O’Connor M, Hunt KN, Brandt KR, Vachon CM. Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study. Breast Cancer Research 2016, 18: 42. PMID: 27113363, PMCID: PMC4845425, DOI: 10.1186/s13058-016-0704-6.Peer-Reviewed Original ResearchConceptsBackground parenchymal uptakeCase-control studyBreast cancer casesRisk factorsBreast cancerCancer casesParenchymal uptakeIncident breast cancer casesBreast cancer risk factorsRetrospective case-control studyDense breastsConditional logistic regression analysisInvasive breast cancer casesPostmenopausal hormone useCancer risk factorsFunctional imaging biomarkersBreast cancer riskLogistic regression analysisBI-RADS densityPostmenopausal womenEligible womenMenopausal statusHormone useMedian ageSupplemental screening
2013
Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial
Sood R, Warndahl RA, Schroeder DR, Singh RJ, Rhodes DJ, Wahner-Roedler D, Bahn RS, Shuster LT. Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial. Maturitas 2013, 74: 375-382. PMID: 23384975, DOI: 10.1016/j.maturitas.2013.01.010.Peer-Reviewed Original ResearchConceptsClinical trialsEstradiol patchLarge clinical trialsRandomized clinical trialsSerum progesterone levelsStudy medicationOral progesteronePostmenopausal womenHormone therapyEstriol levelsSerum levelsStudy armsEstrogen creamPharmacokinetic trialProgesterone levelsComparable dosesHormonal preparationsPharmacokinetic evaluationPharmacokinetic informationDosesTrialsFurther studiesEstrogenProgesteroneBioidentical
2000
Breast cancer prevention trials
Rhodes D, Hartmann L, Perez E. Breast cancer prevention trials. Current Oncology Reports 2000, 2: 558-565. PMID: 11122893, DOI: 10.1007/s11912-000-0110-0.Peer-Reviewed Original ResearchConceptsBreast Cancer Prevention TrialCancer Prevention TrialBreast cancer incidenceBreast cancerPrevention trialsCancer incidenceBowel Project Breast Cancer Prevention TrialPrimary breast cancer preventionNational Surgical Adjuvant BreastEffectiveness of raloxifeneEfficacy of tamoxifenBreast cancer preventionHormone replacement therapyAdjuvant BreastPostmenopausal womenRandomized trialsReplacement therapyDrug therapyCancer preventionStudy populationEligibility criteriaChemopreventive agentsTamoxifenTreatment planRaloxifene